ILEP WEBINARS 2020 – 2nd Edition
Let’s uncover all the secrets of nutraceuticals! Why, when, what patients might benefit the most! Recommendations 2020/2021
Part 1 – Nutraceuticals I
Date: 23rd September 2020, 7-9 PM CEST.
Moderator: Prof. Maciej Banach
Experts:
 |
 |
 |
 |
| Prof. Maciej Banach Polish Mother’s Memorial Hospital – Research Institute, Lodz (Poland) |
Prof. Peter Penson Liverpool John Moores University, Liverpool, UK |
Prof. Dan Gaita Institute of Cardiovascular Medicine, Timisoara (Romania) |
Prof. Matteo Pirro University of Perugia (Italy) |
-Few words on history of nutraceuticals, what should be the properties of good nutraceutical/functional food, and why we need them? Whether lifestyle changes with correct diet might be not enough? Prof. Peter Penson (Liverpool, UK)
-The role of nutraceuticals in the improving of the lipid profile in patients with dyslipidemia. EAS/ESC, American and ILEP recommendations. Monotherapy or polypills? Prof. Dan Gaita (Timisoara, Romania)
-How important is early intervention to reduce LDL-C in patients with low to moderate risk? Might it be any complementary role of nutraceuticals in severe hypercholesterolemia, including FH? Prof. Maciej Banach (Lodz, Poland)
-Real-life case reports on the application of nutraceuticals in patients at different cardiovascular risk. Prof. Matteo Pirro (Perugia, Italy)
Part 1 – Nutraceuticals II
Date: 1st October 2020, 7-9 PM CEST.
Moderator: Prof. Arrigo Cicero and Prof. Maciej Banach
Experts:
|
 |
 |
 |
| Prof. Maciej Banach Polish Mother’s Memorial Hospital – Research Institute, Lodz (Poland) |
Prof. Željko Reiner University Hospital Centre Zagreb, Zagreb (Croatia) |
Prof. Arrigo Cicero University of Bologna (Bologna, Italy) |
Prof. Niki Katsiki Aristotle University of Thessaloniki (Greece) |
-The role of nutraceuticals in high and very high-risk patients not being on the goal. Whether nutraceuticals might be of real help? Prof. Zeljko Reiner (Zagreb, Croatia)
-The management of statin intolerance based on ILEP recommendations 2020. What is the place and role of nutraceuticals? Prof. Maciej Banach (Lodz, Poland)
-The potential place of nutraceuticals in other populations of patients (inflammation or Lp(a)-related residual risk), heart failure? Prof. Arrigo Cicero (Bologna, Italy)
-Let’s talk about nutraceuticals safety. What is nutrivigilance? Prof. Niki Katsiki (Thessaloniki, Greece).
Webinar partners